From August 19 to 20, 2023, the founding meeting of the Cell Medicine Branch of China Food and Drug Enterprise Quality and Safety Promotion Association and the high-quality Development Forum of Cell medicine were successfully held in Beijing Daxing Long Xiweijing International Conference Center, and Professor Shi Yuanyuan, chairman of the board, was invited to attend and preside over the meeting.

The establishment meeting of Cell Medicine Branch of China Food and Drug Enterprise Quality and Safety Promotion Association was presided over by Professor Shi Yuanyuan, chairman of our company.


First, Mao Zhenbin, the former director of the Inspection Bureau of the former National Food and Drug Administration and the candidate president of the second session of the China Food and Drug Promotion Association, solemnly presented the plaque of the "Cell Medicine Branch". Immediately after, he issued the appointment letters of vice president of the "Cell Medicine Branch" to Professors Wu Zhihong, Shi Yuanyuan, Xiong Lei, Chen Jiekai, Yin Mingzhu and Chen Zhe. Professor Wu Zhihong was presented with the letter of appointment as the director of the "Cell Medicine Branch" expert committee. Our company's chief scientist, Professor Wang Jianxun, was appointed as the deputy director of the expert committee. Subsequently, Professor Chen Junhui and Professor Wu Zhihong issued the "Appointment Letter of Deputy Chairman of the Expert Committee of the Cell Medicine Branch" to all the expert members.

In the high-quality development forum of the cell medicine industry held later, Dr. Fu Yuchen, senior research and development scientist of our company, gave a keynote speech on the Establishment of a standardized industrial production system for cell and gene therapy carriers. The background and development prospect of cell and gene therapy industry, the selection of vectors (comparative analysis of lentivirus and retrovirus), the establishment of standardized industrial production system of viral vectors, and the development process, technical team and enterprise strength of Shenzhen Cell Valley were introduced. And said that cell and gene therapy with the progress of science and technology and people's increasing attention to health, the market application prospects are growing, can provide new ideas for the treatment of cancer treatment, cancer treatment and other fields of disease, and contribute to the improvement of the treatment effect and the improvement of the quality of life of patients.